How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis.

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · see citing works

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.

Polman, C., O'Connor, P., Havrdová, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J., Lublin, F., Giovannoni, G., Wajgt, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044397 · Cited by 3,293 · see citing works

Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin

Yednock, T. A., Cannon, C., Fritz, L. C., Sánchez‐Madrid, F., Steinman, L., & Karin, N. (1992) · Nature · doi:10.1038/356063a0 · Cited by 1,737 · see citing works

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E. E., Garren, H., Langer-Gould, A. M., Strober, S., Cannella, B., Allard, J. D., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669 · see citing works

Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis

Johnson, K., Brooks, B., Cohen, J. A., Ford, C., Goldstein, J., Lisak, R., Myers, L., Panitch, H., Rose, J., Schiffer, R., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1268 · Cited by 1,667 · see citing works

The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors

Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E. E., Baumruker, T., HIESTAND, P. C., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,506 · see citing works

Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

Rudick, R. A., Stuart, W. H., Calabresi, P. A., Confavreux, C., Galetta, S. L., Radue, E. W., LUBLIN, F. D., Weinstock‐Guttman, B., Wynn, D. R., Lynn, F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044396 · Cited by 1,342 · see citing works

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

Youssef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,098 · see citing works

The T lymphocyte in experimental allergic encephalomyelitis.

Zamvil, S., & Steinman, L. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.003051 · Cited by 1,091 · see citing works

TNF neutralization in MS

The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,060 · see citing works

TNFα promotes proliferation of oligodendrocyte progenitors and remyelination

Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P.-Y. (2001) · Nature Neuroscience · doi:10.1038/nn738 · Cited by 1,012 · see citing works

Identification of autoantibodies associated with myelin damage in multiple sclerosis

Genain, C. P., Cannella, B., Hauser, S. L., & Raine, C. S. (1999) · Nature Medicine · doi:10.1038/5532 · Cited by 891 · see citing works

The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease

Chabas, D., Baranzini, S. E., Mitchell, D., Bernard, C. C. A., Rittling, S. R., Denhardt, D. T., Sobel, R. A., Lock, C., Karpuj, M., Pedotti, R., et al. (2001) · Science · doi:10.1126/science.1062960 · Cited by 829 · cited 14× · see citing works

Myelin Oligodendrocyte Glycoprotein–specific T Cell Receptor Transgenic Mice Develop Spontaneous Autoimmune Optic Neuritis

Bettelli, E., Pagany, M., Weiner, H. L., Linington, C., Sobel, R. A., & Kuchroo, V. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021603 · Cited by 828 · see citing works

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand

Bielekova, B., Goodwin, B. L., Richert, N. D., Cortese, I. C. M., Kondo, T., Afshar, G., Gran, B., Eaton, J. K., Antel, J. P., Frank, J. A., et al. (2000) · Nature Medicine · doi:10.1038/80516 · Cited by 823 · see citing works

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2

van Oosten, B. W., Barkhof, F., Truyen, L., Boringa, J., Bertelsmann, F. W., Blomberg, B. M. E. V., Woody, J. N., Hartung, H., & Polman, C. H. (1996) · Neurology · doi:10.1212/wnl.47.6.1531 · Cited by 735 · see citing works

THE INFLUENCE OF THE PROINFLAMMATORY CYTOKINE, OSTEOPONTIN, ON AUTOIMMUNE DEMYELINATING DISEASE

Chabas, D., Baranzini, S. E., Mitchell, D. J., Bernard, C. C. A., Rittling, S. R., Denhardt, D. T., Sobel, R. A., Lock, C., Karpuj, M. V., Pedotti, R., et al. (2002) · International Conference on Osteopontin and SIBLING Proteins · doi:10.1100/tsw.2002.326 · Cited by 729 · see citing works

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis.

Ruddle, N. H., Bergman, C. M., McGrath, K. M., Lingenheld, E. G., Grunnet, M. L., Padula, S. J., & Clark, R. B. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.4.1193 · Cited by 689 · see citing works

Statin therapy and autoimmune disease: from protein prenylation to immunomodulation

Greenwood, J., Steinman, L., & Zamvil, S. S. (2006) · Nature reviews. Immunology · doi:10.1038/nri1839 · Cited by 685 · see citing works

OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS

Rivers, T. M., Sprunt, D. H., & Berry, G. P. (1933) · Journal of Experimental Medicine · doi:10.1084/jem.58.1.39 · Cited by 643 · see citing works

TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination

Liu, J., Marino, M. W., Wong, G., Grail, D., Dunn, A. R., Bettadapura, J., Slavin, A., Old, L. J., & Bernard, C. C. A. (1998) · Nature Medicine · doi:10.1038/nm0198-078 · Cited by 548 · see citing works

T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination

Zamvil, S. S., Nelson, P. A., Trotter, J., Mitchell, D. J., Knobler, R., Fritz, R. B., & Steinman, L. (1985) · Nature · doi:10.1038/317355a0 · Cited by 532 · see citing works

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial

Kappos, L., Comi, G., PANITCH, H. S., Oger, J. J.-F., Antel, J. P., Conlon, P. J., Steinman, L., Comı, G., Kappos, L., Oger, J. J.-F., et al. (2000) · Nature Medicine · doi:10.1038/80525 · Cited by 512 · see citing works

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

Vollmer, T. R., Key, L., Durkalski, V., Tyor, W. R., Corboy, J. R., Markovic‐Plese, S., Preiningerova, J. L., Rizzo, M., & Singh, I. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16205-3 · Cited by 471 · see citing works

A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple Sclerosis

Bornstein, M. B., Miller, A., Slagle, S., Weitzman, M., Crystal, H., Drexler, E. D., Keilson, M. J., Merriam, A. E., Wassertheil-Smoller, S. W., Spada, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708133170703 · Cited by 462 · see citing works

Anti—tumor necrosis factor therapy abrogates autoimmune demyelination

Selmaj, K. W., Raine, C. S., & Cross, A. H. (1991) · Annals of Neurology · doi:10.1002/ana.410300510 · Cited by 441 · see citing works

Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide

Teitelbaum, D., Meshorer, A., Hirshfeld, T., Arnon, R., & Sela, M. (1971) · European Journal of Immunology · doi:10.1002/eji.1830010406 · Cited by 433 · see citing works

Glatiramer acetate (Copaxone®) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis

Duda, P. W., Schmied, M. C., Cook, S. L., Krieger, J. I., & Hafler, D. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8970 · Cited by 416 · see citing works

GENETIC CONTROL OF THE ANTIBODY RESPONSE

McDevitt, H. O., & Sela, M. (1965) · The Journal of Experimental Medicine · doi:10.1084/jem.122.3.517 · Cited by 404 · see citing works

Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein

Brocke, S., Gijbels, K., Allegretta, M., Ferber, I., Piercy, C., Blankensteini, T., Martinꝉ, R., Utz, U., Karin, N., Mitchell, D. J., et al. (1996) · Nature · doi:10.1038/379343a0 · Cited by 371 · see citing works

A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor

Madsen, L. S., Andersson, E. C., Jansson, L., Krogsgaard, M., Andersen, C. B., Engberg, J., Strominger, J. L., Svejgaard, A., Hjorth, J. P., Holmdahl, R., et al. (1999) · Nature Genetics · doi:10.1038/15525 · Cited by 335 · see citing works

Uncoupling the Proinflammatory from the Immunosuppressive Properties of Tumor Necrosis Factor (Tnf) at the P55 TNF Receptor Level

Kassiotis, G., & Kollias, G. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.4.427 · Cited by 332 · see citing works

Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab

Steinman, L. (2005) · Nature reviews. Drug discovery · doi:10.1038/nrd1752 · Cited by 328 · see citing works

Lipid microarrays identify key mediators of autoimmune brain inflammation

Kanter, J. L., Narayana, S., Ho, P. P.-K., Catz, I., Warren, K. G., Sobel, R. A., Steinman, L., & Robinson, W. H. (2005) · Nature Medicine · doi:10.1038/nm1344 · Cited by 317 · see citing works

Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β

Bielekova, B., Richert, N. D., Howard, T., Blevins, G., Markovic‐Plese, S., McCartin, J., Wuerfel, J. T., Ohayon, J. M., Waldmann, T. A., McFarland, H. F., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402653101 · Cited by 314 · see citing works

Design of effective immunotherapy for human autoimmunity

Feldmann, M., & Steinman, L. (2005) · Nature · doi:10.1038/nature03727 · Cited by 277 · see citing works

Experimental allergic encephalomyelitis: A misleading model of multiple sclerosis

Sriram, S., & Steiner, I. (2005) · Annals of Neurology · doi:10.1002/ana.20743 · Cited by 264 · see citing works

Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity.

Fridkis‐Hareli, M., Teitelbaum, D., Gurevich, E. P., Pecht, I., Brautbar, C., Kwon, O.-J., Brenner, T., Arnon, R., & Sela, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4872 · Cited by 243 · see citing works

Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor‐immunoglobulin fusion proteins

Baker, D., Butler, D. M., Scallon, B. J., O'Neill, J. K., Turk, J. L., & Feldmann, M. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240916 · Cited by 230 · see citing works

Treatment with laquinimod reduces development of active MRI lesions in relapsing MS

Polman, C. H., Barkhof, F., Sandberg‐Wollheim, M., Linde, A., Nordle, Ö., & Nederman, T. (2005) · Neurology · doi:10.1212/01.wnl.0000154520.48391.69 · Cited by 227 · see citing works

Lovastatin inhibits brain endothelial cell Rho‐mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis

Greenwood, J., Walters, C. E., Pryce, G., Kanuga, N., Bemud, E., Baker, D., & Adamson, P. (2003) · The FASEB Journal · doi:10.1096/fj.02-1014fje · Cited by 227 · see citing works

Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production.

Karin, N., Mitchell, D. J., Brocke, S., LING, N. C., & Steinman, L. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.6.2227 · Cited by 211 · see citing works

Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications

Arnon, R., & Aharoni, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404887101 · Cited by 205 · see citing works

An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide

Pedotti, R., Mitchell, D., Wedemeyer, J., Karpuj, M., Chabas, D., Hattab, E., Tsai, M., Galli, S., & Steinman, L. (2001) · Nature Immunology · doi:10.1038/85266 · Cited by 198 · see citing works

Relapsing experimental allergic encephalomyelitis in the SJL/J mouse.

Brown, A. M., & McFarlin, D. E. (1981) · PubMed · Cited by 196 · see citing works

Therapeutic vaccine for acute and chronic motor neuron diseases: Implications for amyotrophic lateral sclerosis

Angelov, D. N., Waibel, S., Guntinas‐Lichius, O., Lenzen, M., Neiss, W. F., Tomov, T. L., Yoles, E., Kipnis, J., Schori, H., Reuter, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530191100 · Cited by 193 · see citing works

Plasma osteopontin levels in multiple sclerosis.

Comabella, M., Pericot, I., Goertsches, R., Nos, C., Castillo, M., Navarro, J. B., Río, J., & Montalbán, X. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.09.004 · Cited by 184 · see citing works

Apoptosis of Oligodendrocytes via Fas and TNF-R1 Is a Key Event in the Induction of Experimental Autoimmune Encephalomyelitis

Hövelmeyer, N., Hao, Z., Kranidioti, K., Kassiotis, G., Buch, T., Frommer, F., von Hoch, L., Krämer, D., Minichiello, L., Kollias, G. A., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5875 · Cited by 169 · see citing works

The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis

Brunmark, C., Runström, A., Ohlsson, L., Sparre, B., Brodin, T., Åström, M., & Hedlund, G. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00225-4 · Cited by 164 · see citing works

Treatment of multiple sclerosis with an anti–interleukin‐2 receptor monoclonal antibody

ROSE, J. W., Watt, H. E., White, A. T., & Carlson, N. G. (2004) · Annals of Neurology · doi:10.1002/ana.20287 · Cited by 163 · see citing works

Clinical Stabilization and Effective B-Lymphocyte Depletion in the Cerebrospinal Fluid and Peripheral Blood of a Patient With Fulminant Relapsing-Remitting Multiple Sclerosis

Stüve, O., Cepok, S., Elias, B., Saleh, A., Hartung, H.-P., Hemmer, B., & Kieseier, B. C. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1620 · Cited by 149 · see citing works

Interferon-β inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis

Yu, M., Nishiyama, A., Trapp, B. D., & Tuohy, V. K. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00160-3 · Cited by 147 · see citing works

Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis

Stanislaus, R., Singh, A. K., & Singh, I. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1207 · Cited by 140 · see citing works

Transcriptional analysis of targets in multiple sclerosis

Steinman, L., & Zamvil, S. (2003) · Nature reviews. Immunology · doi:10.1038/nri1108 · Cited by 135 · see citing works

Elevated osteopontin levels in active relapsing‐remitting multiple sclerosis

Vogt, M., Lopatinskaya, L., Smits, M., Polman, C., & Nagelkerken, L. (2003) · Annals of Neurology · doi:10.1002/ana.10606 · Cited by 131 · see citing works

Suppression of experimental allergic encephalomyelitis in rhesus monkeys by a synthetic basic copolymer

Teitelbaum, D., Webb, C., Bree, M. M., Meshorer, A., Arnon, R., & Sela, M. (1974) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(74)90012-9 · Cited by 126 · see citing works

Suppression by several synthetic polypeptides of experimental allergic encephalomyelitis induced in guinea pigs and rabbits with bovine and human basic encephalitogen

Teitelbaum, D., Webb, C., Meshorer, A., Arnon, R., & Sela, M. (1973) · European Journal of Immunology · doi:10.1002/eji.1830030505 · Cited by 122 · see citing works

Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms

Gaur, A., Boehme, S. A., Chalmers, D. T., Crowe, P. D., Pahuja, A., LING, N. C., Brocke, S., Steinman, L., & Conlon, P. J. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00220-2 · Cited by 118 · see citing works

Promiscuous Binding of Synthetic Copolymer 1 to Purified HLA-DR Molecules

Fridkis‐Hareli, M., & Strominger, J. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4386 · Cited by 111 · see citing works

Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis.

Pomeroy, I., Matthews, P., Frank, J., Jordan, E., & Esiri, M. (2005) · Brain : a journal of neurology · doi:10.1093/brain/awh626 · Cited by 111 · see citing works

Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity

Stüve, O. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25805 · Cited by 107 · see citing works

Fine specificity of the antibody response to myelin basic protein in the central nervous system in multiple sclerosis: the minimal B-cell epitope and a model of its features.

Warren, K. G., Catz, I., & Steinman, L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11061 · Cited by 106 · see citing works

Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87–99)

Vergelli, M., Hemmer, B., Utz, U., Vogt, A. B., Kalbus, M., Tranquill, L. R., Conlon, P. J., LING, N. C., Steinman, L., McFarland, H. F., et al. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261113 · Cited by 95 · see citing works

Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients.

Vogt, M., Floris, S., Killestein, J., Knol, D. L., Smits, M., Barkhof, F., Polman, C., & Nagelkerken, L. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.06.007 · Cited by 94 · see citing works

Suppression of experimental allergic encephalomyelitis by mitoxantrone

Ridge, S. C., Sloboda, A. E., McReynolds, R. A., Levine, S., Oronsky, A. L., & Kerwar, S. S. (1985) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(85)90075-3 · Cited by 94 · see citing works

Effect of a synthetic polypeptide (Cop 1) on patients with multiple sclerosis and with acute disseminated encephalomyelitis

Abramsky, O., Teitelbaum, D., & Arnon, R. (1977) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(77)90220-9 · Cited by 93 · see citing works

Some Misconceptions about Understanding Autoimmunity through Experiments with Knockouts

Steinman, L. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.12.2039 · Cited by 91 · see citing works

Delayed, relapsing experimental allergic encephalomyelitis in mice.

LUBLIN, F. D., Maurer, P. H., Berry, R. G., & Tippett, D. S. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.3.819 · Cited by 87 · see citing works

Identification of T cell subsets and B lymphocytes in mouse brain experimental allergic encephalitis lesions.

Sriram, S., Solomon, D., Rouse, R. V., & Steinman, L. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.4.1649 · Cited by 86 · see citing works

Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus

Genain, C. P., & Hauser, S. L. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1830113.x · Cited by 85 · see citing works

High Incidence of Spontaneous Disease in an HLA-DR15 and TCR Transgenic Multiple Sclerosis Model1

Ellmerich, S., Mycko, M., Takács, K., Waldner, H., Wahid, F., Boyton, R., King, R., Smith, P. A., Amor, S., Herlihy, A., et al. (2005) · Journal of Immunology · doi:10.4049/jimmunol.174.4.1938 · Cited by 83 · see citing works

Genetics of multiple sclerosis

Oksenberg, J. R., & Hauser, S. L. (2005) · Neurologic Clinics · doi:10.1016/j.ncl.2004.09.006 · Cited by 81 · see citing works

Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantrone

LUBLIN, F. D., Lavasa, M., Viti, C., & Knobler, R. L. (1987) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(87)90118-8 · Cited by 76 · see citing works

Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis

Menge, T., Lalive, P. H., von Büdingen, H. ‐., Cree, B., Hauser, S. L., & Genain, C. P. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.03.023 · Cited by 70 · see citing works

Optic Neuritis, A New Variant of Experimental Encephalomyelitis, A Durable Model for All Seasons, Now In Its Seventieth Year

Steinman, L. (2003) · Journal of Experimental Medicine · doi:10.1084/jem.20030320 · Cited by 60 · see citing works

The effect of Cop 1, a synthetic polypeptide, on chronic relapsing experimental allergic encephalomyelitis in guinea pigs

Keith, A. B., Arnon, R., Teitelbaum, D., CASPARY, E. A., & Wisniewski, H. M. (1979) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(79)90058-3 · Cited by 57 · see citing works

A review of systemic nonspecific immunosuppressive treatment of multiple sclerosis

Ellison, G. W., & Myers, L. W. (1978) · Neurology · doi:10.1212/wnl.28.9_part_2.132 · Cited by 52 · see citing works

Selective Treatment of Multiple Sclerosis

Ropper, A. H. (2006) · New England Journal of Medicine · doi:10.1056/nejme068002 · Cited by 47 · see citing works

Autoimmune effector cells. IX. Inhibition of adoptive transfer of autoimmune encephalomyelitis with a monoclonal antibody specific for interleukin 2 receptors.

Hayosh, N. S., & Swanborg, R. H. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.11.3771 · Cited by 37 · see citing works

Protection against Experimental Allergic Encephalomyelitis

Teitelbaum, D., Webb, C., Meshorer, A., Arnon, R., & Sela, M. (1972) · Nature · doi:10.1038/240564b0 · Cited by 37 · see citing works

Therapeutic Effect of the Immunomodulator Glatiramer Acetate on Trinitrobenzene Sulfonic Acid-Induced Experimental Colitis

Aharoni, R., Kayhan, B., & Arnon, R. (2005) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200502000-00003 · Cited by 32 · see citing works

Genomic and proteomic analysis of multiple sclerosis. Opinion.

Robinson, W., Utz, P., & Steinman, L. (2003) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.09.015 · Cited by 30 · see citing works

The Concept of Specific Immune Treatment Against Autoimmune Diseases

Sela, M. (1999) · International Reviews of Immunology · doi:10.3109/08830189909043025 · Cited by 19 · see citing works

Immunomodulatory Vaccines Against Autoimmune Diseases

Sela, M. (2006) · Rejuvenation Research · doi:10.1089/rej.2006.9.126 · Cited by 18 · see citing works

Immunomodulation of Experimental Autoimmune Encephalomyelitis with Ordered Peptides Based on MHC-TCR Binding Motifs

Ruiz, P. J., DeVoss, J., Nguyen, L.-V. T., da Fontoura, P. P., Hirschberg, D. L., Mitchell, D. J., García, K. C., & Steinman, L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2688 · Cited by 15 · see citing works

Restrictive and diversifying elements of the anti-myelin/oligodendrocyte glycoprotein antibody response in primate experimental allergic encephalomyelitis

von Büdingen, H. ‐., Menge, T., Hauser, S. L., & Genain, C. P. (2006) · Immunogenetics · doi:10.1007/s00251-006-0100-y · Cited by 9 · see citing works

Therapeutic approaches to secondary progressive multiple sclerosis

Lublin, F. D. (2002) · Multiple Sclerosis Journal · doi:10.1177/135245850200800119 · Cited by 4 · see citing works

MRI aspects of secondary progressive multiple sclerosis

Wolinsky, J. S. (2002) · Multiple Sclerosis Journal · doi:10.1177/135245850200800118 · Cited by 4 · see citing works

Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)

Constantinescu, C. S., Farooqi, N., O'Brien, K., & Gran, B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01302.x · Cited by 1,523 · see citing works

Treatment of Multiple Sclerosis: A Review

Hauser, S. L., & Cree, B. A. C. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.05.049 · Cited by 969 · see citing works

Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles’ Physicochemical Properties on Responses in Biological Systems

Yusuf, A., Almotairy, A. R. Z., Henidi, H. A., Alshehri, O. Y., & Aldughaim, M. S. (2023) · Polymers · doi:10.3390/polym15071596 · Cited by 925 · see citing works

The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.

Hauser, S., & Oksenberg, J. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.011 · Cited by 820 · see citing works

Myelin in the Central Nervous System: Structure, Function, and Pathology

Stadelmann, C., Timmler, S., Barrantes‐Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 735 · see citing works

Active induction of experimental allergic encephalomyelitis

Stromnes, I. M., & Goverman, J. M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.285 · Cited by 577 · see citing works

NOX Enzymes in the Central Nervous System: From Signaling to Disease

Sorce, S., & Krause, K. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2578 · Cited by 472 · see citing works

The origin and application of experimental autoimmune encephalomyelitis

Baxter, A. G. (2007) · Nature reviews. Immunology · doi:10.1038/nri2190 · Cited by 458 · see citing works

Type II monocytes modulate T cell–mediated central nervous system autoimmune disease

Weber, M. S., Prod'homme, T., Youssef, S., Dunn, S. E., Rundle, C. D., Lee, L., Patarroyo, J. C., Stüve, O., Sobel, R. A., Steinman, L., et al. (2007) · Nature Medicine · doi:10.1038/nm1620 · Cited by 447 · see citing works

Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system

Friese, M. A., Craner, M. J., Etzensperger, R., Vergo, S. B., Wemmie, J. A., Welsh, M. J., Vincent, A. C., & Fugger, L. H. (2007) · Nature Medicine · doi:10.1038/nm1668 · Cited by 408 · see citing works

CD11b+Ly-6Chi Suppressive Monocytes in Experimental Autoimmune Encephalomyelitis

Zhu, B., Bandô, Y., Xiao, S., Yang, K., Anderson, A. C., Kuchroo, V. K., & Khoury, S. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5228 · Cited by 370 · see citing works

Animal models of Multiple Sclerosis

Procaccini, C., Rosa, V. D., Pucino, V., Formisano, L., & Matarese, G. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.042 · Cited by 371 · see citing works

Animal models of multiple sclerosis: the good, the bad and the bottom line

Ransohoff, R. M. (2012) · Nature Neuroscience · doi:10.1038/nn.3168 · Cited by 379 · see citing works

The genetics of multiple sclerosis: SNPs to pathways to pathogenesis

Oksenberg, J. R., Baranzini, S. E., Sawcer, S., & Hauser, S. L. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2395 · Cited by 347 · see citing works

The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease?

Weiner, H. L. (2009) · Annals of Neurology · doi:10.1002/ana.21640 · Cited by 342 · see citing works

B‐cell activation influences T‐cell polarization and outcome of anti‐CD20 B‐cell depletion in central nervous system autoimmunity

Weber, M. S., Prod’homme, T., Patarroyo, J. C., Molnarfi, N., Karnezis, T., Lehmann‐Horn, K., Danilenko, D. M., Eastham‐Anderson, J., Slavin, A., Linington, C., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22081 · Cited by 321 · see citing works

Suppressive Effect of IL-27 on Encephalitogenic Th17 Cells and the Effector Phase of Experimental Autoimmune Encephalomyelitis

Fitzgerald, D. C., Ćirić, B., Touil, T., Harle, H., Grammatikopolou, J., Sarma, J. D., Gran, B., Zhang, G., & Rostami, A. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3268 · Cited by 307 · see citing works

IL ‐33 attenuates EAE by suppressing IL ‐17 and IFN ‐γ production and inducing alternatively activated macrophages

Jiang, H., Milovanović, M., Allan, D., Niedbała, W., Besnard, A., Fukada, S. Y., Alves-Filho, J. C., Togbe, D., Goodyear, C. S., Linington, C., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201141947 · Cited by 307 · see citing works

Activation of the Cholinergic Anti-Inflammatory System by Nicotine Attenuates Neuroinflammation via Suppression of Th1 and Th17 Responses

Nizri‏, E., Irony-Tur-Sinai, M., Lory, O., Orr‐Urtreger, A., Lavi, E., & Brenner, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902212 · Cited by 308 · see citing works

The relevance of animal models in multiple sclerosis research

Đenić, A., Johnson, A. J., Bieber, A. J., Warrington, A. E., Rodriguez, M., & Pirko, I. (2010) · Pathophysiology · doi:10.1016/j.pathophys.2010.04.004 · Cited by 300 · see citing works

Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis

Ephrem, A., Chamat, S., Miquel, C., Fisson, S., Mouthon, L., Caligiuri, G., Delignat, S., Elluru, S. R., Bayry, J., Lacroix‐Desmazes, S., et al. (2007) · Blood · doi:10.1182/blood-2007-03-079947 · Cited by 292 · see citing works

Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination

Rostami, A. M., & Ćirić, B. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.03.002 · Cited by 275 · see citing works

The role of antigen presenting cells in multiple sclerosis

Chastain, E. M. L., Duncan, D. S., Rodgers, J. M., & Miller, S. D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.008 · Cited by 264 · see citing works

Neutrophil-related factors as biomarkers in EAE and MS

Rumble, J. M., Huber, A. K., Krishnamoorthy, G., Srinivasan, A., Giles, D. A., Zhang, X., Wang, L., & Segal, B. M. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20141015 · Cited by 262 · see citing works

Interleukin-17 in chronic inflammatory neurological diseases

Milovanovic, J., Arsenijevic, A., Stojanovic, B., Kanjevac, T., Arsenijevic, D., Radosavljevic, G., Milovanovic, M., & Arsenijevic, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00947 · Cited by 250 · see citing works

Natalizumab for Multiple Sclerosis

Ransohoff, R. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmct071462 · Cited by 255 · see citing works

Regulation of Activated CD4+ T Cells by NK Cells via the Qa-1–NKG2A Inhibitory Pathway

Lu, L., Ikizawa, K., Hu, D., Werneck, M. B. F., Wucherpfennig, K. W., & Cantor, H. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.017 · Cited by 253 · see citing works

Is multiple sclerosis a mitochondrial disease?

Mao, P., & Reddy, P. H. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.07.002 · Cited by 242 · see citing works

Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis

Piccio, L. M., Stark, J. L., & Cross, A. H. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0208133 · Cited by 235 · see citing works

Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders

Chiu, C., & Chuang, D. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.07.006 · Cited by 226 · see citing works

Effects of Panax ginseng in Neurodegenerative Diseases

Cho, I. (2012) · Journal of Ginseng Research · doi:10.5142/jgr.2012.36.4.342 · Cited by 225 · see citing works

Passive induction of experimental allergic encephalomyelitis

Stromnes, I. M., & Goverman, J. M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.284 · Cited by 224 · see citing works

Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis

Forte, M., Gold, B., Marracci, G., Chaudhary, P., Basso, E., Johnsen, D., Yu, X.-L., Fowlkes, J., Rahder, M., Stem, K., et al. (2007) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0702228104 · Cited by 222 · see citing works

Animal models of multiple sclerosis—Potentials and limitations

Mix, E., Meyer-Rienecker, H., Hartung, H., & Zettl, U. K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.005 · Cited by 210 · see citing works

Lactobacillus reuteri tryptophan metabolism promotes host susceptibility to CNS autoimmunity

Montgomery, T. L., Eckstrom, K. M., Lile, K. H., Caldwell, S. K., Heney, E. R., Lahue, K. G., D’Alessandro, A., Wargo, M. J., & Krementsov, D. N. (2022) · Microbiome · doi:10.1186/s40168-022-01408-7 · Cited by 200 · see citing works

The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets

Hohlfeld, R., Dornmair, K., Meinl, E., & Wekerle, H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00334-8 · Cited by 197 · see citing works

Galectin-3 Deficiency Reduces the Severity of Experimental Autoimmune Encephalomyelitis

Jiang, H., Rasbi, Z. A., Mensah‐Brown, E. P. K., Shahin, A., Xu, D., Goodyear, C. S., Fukada, S. Y., Liu, F., Liew, F. Y., & Lukić, M. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.2.1167 · Cited by 188 · see citing works

Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins

Brändle, S. M., Obermeier, B., Şenel, M., Bruder, J., Mentele, R., Khademi, M., Olsson, T. P., Tumani, H., Kristoferitsch, W., Lottspeich, F., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522730113 · Cited by 190 · see citing works

The complement cascade: Yin-Yang in neuroinflammation—neuro-protection and -degeneration

Alexander, J. J., Anderson, A. J., Barnum, S. R., Stevens, B., & Tenner, A. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05668.x · Cited by 177 · see citing works

Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

Arellano, G., Ottum, P. A., Reyes, L. I., Burgos, P. I., & Naves, R. F. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00492 · Cited by 174 · see citing works

EAE: imperfect but useful models of multiple sclerosis

Hart, B. A. ‘., Gran, B., & Weissert, R. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.11.006 · Cited by 169 · see citing works

Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE)

Olechowski, C. J., Truong, J. J., & Kerr, B. J. (2009) · Pain · doi:10.1016/j.pain.2008.11.002 · Cited by 159 · see citing works

Defining distinct features of anti-MOG antibody associated central nervous system demyelination

Weber, M. S., Derfuss, T. J., Metz, I., & Brück, W. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418762083 · Cited by 160 · see citing works

Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis

Soulika, A., Lee, E., Mccauley, E., Miers, L., Bannerman, P., & Pleasure, D. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3794-09.2009 · Cited by 146 · see citing works

Environmental factors in autoimmune diseases and their role in multiple sclerosis

Haase, S., Grohme, D. A., Erzler, M., Binsfeld, M., Haghikia, A., Müller, D. N., Linker, R. A., & Kleinewietfeld, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2311-1 · Cited by 152 · see citing works

Latency-Associated Peptide Identifies a Novel CD4+CD25+ Regulatory T Cell Subset with TGFβ-Mediated Function and Enhanced Suppression of Experimental Autoimmune Encephalomyelitis

Chen, M., Yan, B., Bandô, Y., Kuchroo, V. K., & Weiner, H. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7327 · Cited by 146 · see citing works

The Transcription Factor IRF8 Activates Integrin-Mediated TGF-β Signaling and Promotes Neuroinflammation

Yoshida, Y., Yoshimi, R., Yoshii, H., Kim, D., Dey, A., Xiong, H., Munasinghe, J., Yazawa, I., O'Donovan, M. J., Maximova, O. A., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.11.022 · Cited by 145 · see citing works

Inherited and acquired disorders of myelin: The underlying myelin pathology

Duncan, I. D., & Radcliff, A. B. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.04.002 · Cited by 137 · see citing works

Oestrogen receptor β ligand: a novel treatment to enhance endogenous functional remyelination

Crawford, D. K., Mangiardi, M., Song, B., Patel, R., Du, S., Sofroniew, M. V., Voskuhl, R. R., & Tiwari-Woodruff, S. K. (2010) · Brain · doi:10.1093/brain/awq237 · Cited by 134 · see citing works

Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine

Nizri‏, E., Irony-Tur-Sinai, M., Faranesh, N., Lavon, I., Lavi, E., Weinstock, M., & Brenner, T. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.06.018 · Cited by 129 · see citing works

Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis

Martinꝉ, R., Sospedra, M., Rosito, M., & Engelhardt, B. (2016) · European Journal of Immunology · doi:10.1002/eji.201646485 · Cited by 125 · see citing works

Multiple sclerosis: molecular pathogenesis and therapeutic intervention

Boutitah-Benyaich, I., Eixarch, H., Villacieros‐Álvarez, J., Hervera, A., Cobo‐Calvo, Á., Montalbán, X., & Espejo, C. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02415-4 · Cited by 136 · see citing works

Current Concepts in Multiple Sclerosis: Autoimmunity Versus Oligodendrogliopathy

Nakahara, J., Maeda, M., Aiso, S., & Suzuki, N. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-011-8287-6 · Cited by 126 · see citing works

Current and emerging disease‐modulatory therapies and treatment targets for multiple sclerosis

Piehl, F. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13215 · Cited by 125 · see citing works

Acute Disseminated Encephalomyelitis: Clinical and Pathogenesis Features

Noorbakhsh, F., Johnson, R., Emery, D., & Power, C. (2008) · Neurologic clinics · doi:10.1016/j.ncl.2008.03.009 · Cited by 106 · see citing works

Re-Examining the Role of TNF in MS Pathogenesis and Therapy

Fresegna, D., Bullitta, S., Musella, A., Rizzo, F. R., Vito, F. D., Guadalupi, L., Caioli, S., Balletta, S., Sanna, K., Dolcetti, E., et al. (2020) · Cells · doi:10.3390/cells9102290 · Cited by 117 · see citing works

Interactions between host genetics and gut microbiota determine susceptibility to CNS autoimmunity

Montgomery, T. L., Künstner, A., Kennedy, J. J., Fang, Q., Asarian, L., Culp‐Hill, R., D’Alessandro, A., Teuscher, C., Busch, H. S., & Krementsov, D. N. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002817117 · Cited by 117 · see citing works

Human Endogenous Retrovirus Protein Activates Innate Immunity and Promotes Experimental Allergic Encephalomyelitis in Mice

Perron, H., Dougier, H.-L., Lomparski, C., Popa, I., Firouzi, R., Bertrand, J., Marušić, S., Portoukalian, J., Jouvin‐Marche, E., VILLIERS, C. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080128 · Cited by 117 · see citing works

Characterization of relapsing–remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice

Berard, J. L., Wolak, K., Fournier, S., & David, S. (2010) · Glia · doi:10.1002/glia.20935 · Cited by 147 · see citing works

The Contribution of Immune and Glial Cell Types in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

Duffy, S. S., Lees, J. G., & Moalem‐Taylor, G. (2014) · Multiple Sclerosis International · doi:10.1155/2014/285245 · Cited by 115 · see citing works

Dual roles of PGE 2 -EP4 signaling in mouse experimental autoimmune encephalomyelitis

Esaki, Y., Li, Y., Sakata, D., Yao, C., Segi‐Nishida, E., Matsuoka, T., Fukuda, K., & Narumiya, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915112107 · Cited by 117 · see citing works

Interferon-β exacerbates Th17-mediated inflammatory disease

Axtell, R. C., Raman, C., & Steinman, L. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.03.008 · Cited by 111 · see citing works

Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges

Lehmann-Horn, K., Kronsbein, H., & Weber, M. S. (2013) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285612474333 · Cited by 116 · see citing works

Complement in multiple sclerosis: its role in disease and potential as a biomarker

Ingram, G., Hakobyan, S. A., Robertson, N. P., & Morgan, B. P. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03830.x · Cited by 111 · see citing works

Animal Models of MS Reveal Multiple Roles of Microglia in Disease Pathogenesis

Gao, Z., & Tsirka, S. E. (2011) · Neurology Research International · doi:10.1155/2011/383087 · Cited by 103 · see citing works

The Emerging Role of p38 Mitogen-Activated Protein Kinase in Multiple Sclerosis and Its Models

Krementsov, D. N., Thornton, T. M., Teuscher, C., & Rincón, M. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00688-13 · Cited by 103 · see citing works

Stress and hypothalamic–pituitary–adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis—A review

Heesen, C., Gold, S. M., Huitinga, I., & Reul, J. M. H. M. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.05.002 · Cited by 102 · see citing works

Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis

Moscarello, M. A., Lei, H., Mastronardi, F. G., Winer, S., Tsui, H., Li, Z., Ackerley, C. A., Zhang, L., Raijmakers, R., & Wood, D. D. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010520 · Cited by 99 · see citing works

Critical appraisal of animal models of multiple sclerosis

Baker, D., Gerritsen, W. H., Rundle, J., & Amor, S. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511398885 · Cited by 99 · see citing works

Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis

Tan, Y., Abad, C., Lopez, R., Dong, H., Liu, S., Lee, A. W., Gomariz, R. P., Leceta, J., & Waschek, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812257106 · Cited by 99 · see citing works

Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats

Chen, G. Q., Chen, Y., Wang, X. S., Wu, S. Z., Yang, H. M., Xu, H., He, J. C., Wang, X. T., Chen, J., & Zheng, R. Y. (2009) · Brain Research · doi:10.1016/j.brainres.2009.10.054 · Cited by 99 · see citing works

The cannabinoid system and microglia in health and disease

Duffy, S. S., Hayes, J. P., Fiore, N. T., & Moalem‐Taylor, G. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108555 · Cited by 96 · see citing works

Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis

Kalyvas, A., Baskakis, C., Magrioti, V., Constantinou‐Kokotou, V., Stephens, D. L., López‐Vales, R., Lu, J., Yong, V. W., Dennis, E. A., Kokotos, G., et al. (2009) · Brain · doi:10.1093/brain/awp002 · Cited by 97 · see citing works

Behavioral and pathological outcomes in MOG 35–55 experimental autoimmune encephalomyelitis

Jones, M., Nguyen, T. T., DeBoy, C. A., Griffin, J. W., Whartenby, K. A., Kerr, D. A., & Calabresi, P. A. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.05.013 · Cited by 96 · see citing works

Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis

Ge, Z., Da, Y., Xue, Z., Zhang, K., Zhuang, H., Peng, M., Li, Y., Li, W., Simard, A. R., Hao, J., et al. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.12.006 · Cited by 96 · see citing works

Multiple sclerosis therapeutics

Wiendl, H., & Hohlfeld, R. (2009) · Neurology · doi:10.1212/01.wnl.0000344417.42972.54 · Cited by 93 · see citing works

Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?

Mähler, A., Mandel, S. A., Lorenz, M., Rüegg, U. T., Wanker, E. E., Boschmann, M., & Paul, F. (2013) · The EPMA Journal · doi:10.1186/1878-5085-4-5 · Cited by 96 · see citing works

Production of CCL2 by Central Nervous System Cells Regulates Development of Murine Experimental Autoimmune Encephalomyelitis through the Recruitment of TNF- and iNOS-Expressing Macrophages and Myeloid Dendritic Cells

Dogan, R.-N. E., Elhofy, A., & Karpus, W. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7376 · Cited by 93 · see citing works

Harmful and Protective Effects of Phenolic Compounds from African Medicinal Plants

Mbaveng, A. T., Zhao, Q., & Kuete, V. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-800018-2.00020-0 · Cited by 92 · see citing works

Update on Inflammation, Neurodegeneration, and Immunoregulation in Multiple Sclerosis

Bennett, J. L., & Stüve, O. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181880359 · Cited by 92 · see citing works

Animal models of human disease: Inflammation

Webb, D. R. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.014 · Cited by 90 · see citing works

Animal models of multiple sclerosis for the development and validation of novel therapies – potential and limitations

Mix, E., Meyer-Rienecker, H., & Zettl, U. K. (2008) · Journal of Neurology · doi:10.1007/s00415-008-6003-0 · Cited by 89 · see citing works

Assessing Optic Nerve Pathology with Diffusion MRI: from Mouse to Human

Xu, J.-Q., Sun, S.-W., Naismith, R. T., Snyder, A. Z., Cross, A. H., & Song, S.-K. (2008) · NMR in Biomedicine · doi:10.1002/nbm.1307 · Cited by 99 · see citing works

Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases

Ren, G., Li, J., Zhang, X., Wang, Y., Xiao, Y., Zhang, X., Liu, X., Zhang, W., Ma, W., Zhang, J., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abe2933 · Cited by 87 · see citing works

Therapeutic Effects of Systemic Administration of Chaperone αB-Crystallin Associated with Binding Proinflammatory Plasma Proteins*

Rothbard, J., Kurnellas, M. P., Brownell, S., Adams, C. M., Su, L., Axtell, R., Chen, R., Fathman, C., Robinson, W., & Steinman, L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.337691 · Cited by 90 · see citing works

The meninges: new therapeutic targets for multiple sclerosis

Russi, A. E., & Brown, M. A. (2014) · Translational research · doi:10.1016/j.trsl.2014.08.005 · Cited by 89 · see citing works

Analysis of animal-to-human translation shows that only 5% of animal-tested therapeutic interventions obtain regulatory approval for human applications

Ineichen, B., Furrer, E., Grüninger, S., Zurrer, W., & Macleod, M. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002667 · Cited by 113 · see citing works

Helminth therapy and multiple sclerosis

Fleming, J. O. (2013) · International Journal for Parasitology · doi:10.1016/j.ijpara.2012.10.025 · Cited by 83 · see citing works

Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats

Zhang, Z., Zhang, Z., Wu, Y., & Schluesener, H. J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.07.013 · Cited by 84 · see citing works

Impacts of Methylxanthines and Adenosine Receptors on Neurodegeneration: Human and Experimental Studies

Chen, J., & Chern, Y. (2010) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-13443-2_10 · Cited by 81 · see citing works

Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis

Markoullis, K., Sargiannidou, I., Gardner, C., Hadjisavvas, A., Reynolds, R., & Kleopa, K. A. (2012) · Glia · doi:10.1002/glia.22334 · Cited by 83 · see citing works

Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells

Lee, M. J., Jang, M., Choi, J., Chang, B. S., ‍Kim, D. Y., Kim, S., Kwak, Y.-S., Oh, S., Lee, J., Chang, B., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9131-4 · Cited by 82 · see citing works

Optic neuritis in the era of biomarkers

Chen, J. J.-W., Pittock, S. J., Flanagan, E. P., Lennon, V. A., & Bhatti, M. T. (2019) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2019.08.001 · Cited by 81 · see citing works

The good and the bad of neuroinflammation in multiple sclerosis

Naegele, M., & Martinꝉ, R. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52001-2.00003-0 · Cited by 81 · see citing works

MR diffusion changes correlate with ultra-structurally defined axonal degeneration in murine optic nerve

Wu, Q., Butzkueven, H., Gresle, M. M., Kirchhoff, F., Friedhuber, A. M., Yang, Q., Wang, H., Fang, K., Lei, H. C., Egan, G. F., et al. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.06.029 · Cited by 80 · see citing works

Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant

Massey, J. C., Sutton, I. J., Ma, D. D. F., & Moore, J. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00410 · Cited by 80 · see citing works

An overall view of the most common experimental models for multiple sclerosis

Dedoni, S., Scherma, M., Camoglio, C., Siddi, C., Dazzi, L., Puliga, R., Frau, J., Cocco, E., & Fadda, P. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106230 · Cited by 79 · see citing works

Galectin-3: Roles in Neurodevelopment, Neuroinflammation, and Behavior

Srejovic, I. M., Selaković, D., Jovicic, N. U., Jakovljevic, V. L., Lukić, M. L., & Rosic, G. L. (2020) · Biomolecules · doi:10.3390/biom10050798 · Cited by 77 · see citing works

Facets of Theiler’s Murine Encephalomyelitis Virus-Induced Diseases: An Update

Gerhauser, I., Hansmann, F., Ciurkiewicz, M., Löscher, W., & Beineke, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020448 · Cited by 76 · see citing works

CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells

Poppensieker, K., Otte, D.-M., Schürmann, B., Limmer, A., Dresing, P., Drews, E., Schumak, B., Klotz, L., Raasch, J., Mildner, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114153109 · Cited by 76 · see citing works

Experimental allergic encephalomyelitis: A misleading model of multiple sclerosis

Sriram, S., & Steiner, I. (2005) · Annals of Neurology · doi:10.1002/ana.20743 · Cited by 264 · see citing works

Experimental Autoimmune Encephalomyelitis Model for Discovery of New Therapy for Multiple Sclerosis

Singhal, M., & Srivastava, P. (2012) · Cited by 1 · see citing works

The experimental autoimmune encephalomyelitis (EAE) model of MS

(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52001-2.00008-x · Cited by 464 · see citing works

Experimental Allergic Encephalomyelitis as a Model of Multiple Sclerosis

Alvord, E. C. (1989) · Springer eBooks · doi:10.1007/978-1-4613-0777-8_13

Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann Neurol 2005;58: 939–945

Sriram, S., & Steiner, I. (2015)